• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number ETBF3220C166EE
Device Problem No Apparent Adverse Event (3189)
Patient Problems Death (1802); Unspecified Infection (1930)
Event Date 12/27/2014
Event Type  Death  
Event Description
An endurant stent graft system was implanted in a patient for the endovascular treatment of an abdominal aortic aneurysm.It was reported one month post implant there was swelling visible on a ct which also showed a compression of the aortic wall and this was in retrospect was described as the beginning of a post-operative complication / infection.Additional this may have occurred at the primary surgery (smear: enterococci) and it is also possible the prosthesis itself was a source of infection.The patient died due to the infected aneurysm with spondylodiscitis as well as entreococcen bacteria.The physician is not sure that the prosthesis by itself is the source of the bacterial contamination.The physician stated the event was related to the device and procedure.Review of cta¿s from 4 days post-implant revealed that the endurant bifurcate was currently positioned just below the renal arteries.The ipsilateral limb was placed down into the right common iliac artery, and the contralateral limb into the left common iliac.The proximal stent graft od measured 25mm just below the renal arteries.The maximum diameter aaa measured 5.5cm.There was contrast feeding the sac from the ima; no stent graft endoleak was observed.Both limbs were patent.Review of cta¿s from 11 days post-implant showed the stent graft positioned just below the renal arteries.The maximum diameter aaa was stable at 5.5cm.Contrast is again seen in the anterior sac from retrograde flow from the ima, and there is also possible inflow from a posterior lumbar near the top of the sac.Both limbs are patent and no other stent graft issues are seen.Review of cta¿s from 5 months post-implant revealed that the stent graft was in the approximate same in-vivo configuration as the earlier studies.There is no evidence of any endoleak.However the shape of the aaa has a different appearance from the previous studies.The maximum diameter is approximately 5cm.The aneurysm wall appears to have thickened which may be an inflammatory response, and there are air bubbles visible within the sac which may indicate an infection.The origin of the reported infection could not be determined from the films returned.It is possible that the infection could have originated from the implanted stent graft.Alternatively, this could have been the result from a systemic infection that seeded and proliferated on the stent graft material and aaa.
 
Manufacturer Narrative
(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC CARDIOVASCULAR
3576 unocal place
santa rosa CA 95403
Manufacturer Contact
eric elliott
3576 unocal place
santa rosa, CA 95403
7075912586
MDR Report Key4466795
MDR Text Key21773087
Report Number2953200-2015-00175
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/03/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/25/2016
Device Catalogue NumberETBF3220C166EE
Device Lot NumberV04659891
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/03/2015
Initial Date FDA Received01/29/2015
Date Device Manufactured05/26/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age00078 YR
-
-